RadMaps: A Geospatial Framework for Simultaneously Modelling Capacity and Geographic Constraints on Radiotherapy Access

arXiv:2605.23456 · physics.med-ph · Submitted 2026-05-22 · Read on arXiv

Listen

Radio episode about this paper

Transcript

Introduction to the show: ident: Physics. The day in general physics: instruments, methods and results across the field.

Kai: We're looking at the paper: "RadMaps: A Geospatial Framework for Simultaneously Modelling Capacity and Geographic Constraints on Radiotherapy Access".

Mira: Here's the gist of the paper. RadMaps presents an open-source geospatial framework that simultaneously models capacity and geographic constraints on radiotherapy access at any spatial scale This tool is important because it captures the compounding effect of both capacity and geographic constraints to significantly reduce effective access Framework Description RadMaps operates on Uber’s H3 hexagonal grid and integrates population density data with national cancer incidence estimates and radiotherapy facility inventories The framework supports resolutions from Resolution3 (average cell area of 12 400 km2) down to Resolution-7 (5.16 km2) Data sources include Kontur Global Population Density, GLOBOCAN 2022 for cancer incidence estimates, and the IAEA DIRAC database for radiotherapy facilities Travel times are integrated via the TravelTime API using configurable decay functions like uniform, step, or Weibull Demand and Access Modelling Radiotherapy demand is calculated as D = X i λi I i, where I i is the incidence for cancer site i and λi is the radiotherapy utilisation (RTU) rate Demand is apportioned to individual hexagons to establish a local demand per hexagon Dh in proportion to their share of the total population Three metrics are calculated: a capacity-only metric AC, a geography-only metric AG, and the RadMaps combined metric ARM that accounts for both constraints simultaneously Key Findings from Analysis The global analysis at H3 Resolution-3 with a 200 km step-function threshold computes a capacity-only access of 70 %, a geography-only access of 91 %, and a combined radiotherapy access of 60 % High-resolution analyses of six countries demonstrate the tool’s ability to localise access deficits at sub-national scale and reveal distinct access profiles: capacity-limited (United Kingdom), geographically limited (Oman), and doubly-constrained (India and Nigeria) National Contextual Insights The national analyses show that Australia has sufficient capacity to meet its radiotherapy demand in full, while the United States possesses a substantial overall capacity that exceeds demand by more than 70 % India and Nigeria represent doubly-constrained profiles where both absolute capacity and geographical distribution are lacking The combined RadMaps metric ARM = 60 % in the global analysis is significantly lower than either standalone metric, capturing a critical spatial mismatch Limitations and Assumptions The paper notes several assumptions that must be considered when interpreting results, including uniform cancer incidence which distributes cancer incidence uniformly across the population All radiotherapy demand is treated as equivalent, whereas in practice the specific radiotherapy modality and type can vary The greedy nearest-first allocation algorithm assumes that each facility serves its nearest patients first, which may overestimate access in settings where referral patterns diverge significantly from geographic proximity Interpretation should be treated as modelled proxies rather than empirical measures of realised access RadMaps demonstrates the value of simultaneously modelling capacity and geographic constraints on radiotherapy access to produce a combined metric that reveals access deficits not captured by either constraint alone The modular framework is freely available and readily extensible, providing a foundation for larger-scale analyses of radiotherapy access and broader access modelling across diverse geographic and socioeconomic contexts The tool is actively being distributed to healthcare professionals and radiotherapy planners to evaluate its practical utility

Paper summary: Kai: So we're looking at this paper called "RadMaps: A Geospatial Framework for Simultaneously Modelling Capacity and Geographic Constraints on Radiotherapy Access." It’s essentially an open-source framework that tries to model where radiotherapy access is limited by both how many machines there are and how far people have to travel.

Mira: Exactly. The core idea is that existing analyses often look at capacity or geography separately, which means they miss the actual effect when both things hit at once, which significantly reduces effective access. This framework aims to capture that compounding effect across any spatial scale you choose.

Lev: From an engineering standpoint, it’s interesting because it tries to build a system that handles these two different types of constraints simultaneously within one model structure. It suggests a way to look at the problem holistically instead of treating capacity and distance as separate variables.

Kai: The paper uses Uber's H3 hexagonal grid for its spatial modeling, which is a very specific way of dividing the world into manageable units, and it integrates population density data with national cancer incidence estimates and inventories of radiotherapy facilities.

Mira: And it supports resolutions ranging from Resolution-three which has an average cell area of twelve thousand four hundred square kilometers, all the way down to Resolution-seven which is five point one six square kilometers. That gives them a lot of flexibility for different levels of analysis.

Lev: The demand estimation part seems key here too. They calculate radiotherapy demand using cancersite-specific radiotherapy utilisation rates and then apportion that demand across the hexagons based on the share of the total population in that area to get a local demand per hexagon, denoted Dh.

Kai: And then they calculate three specific metrics: a capacity-only metric AC, a geography-only metric AG, and this combined RadMaps metric ARM which accounts for both constraints at the same time. That's what sets it apart from previous work.

Mira: The paper’s main claim is that this combined ARM metric shows a much more realistic picture of access than either AC or AG alone because it captures the compounding effect of those two limitations, significantly reducing effective access in areas where both are constraining.

Lev: When we look at the results they show, they ran a global analysis at H3 Resolution-three with a two hundred km step-function threshold and found a capacity-only access of seventy percent, a geography-only access of ninety-one percent, and the combined radiotherapy access of only sixty percent.

Kai: That drop from ninety one to sixty because they are modeling the interaction between capacity and distance really highlights how much that spatial mismatch matters for real planning decisions. They also looked at six countries with high resolution analyses to see how this works on a smaller scale, showing distinct profiles like capacity-limited in the United Kingdom or geographically limited in Oman.

Mira: That’s a crucial finding because it shows the tool isn't just theoretical; it can pinpoint specific access deficits at sub-national scales and reveal different patterns based on geography and infrastructure availability. India and Nigeria showed up as doubly-constrained profiles where both capacity and distribution were lacking simultaneously.

Lev: The national context insights they pulled from analyzing individual countries are pretty telling, like Australia having enough capacity to meet its demand in full, or the United States having a total capacity that exceeds demand by more than seventy percent.

Kai: But for India and Nigeria, it’s about both absolute capacity and geographical distribution being lacking at the same time. The combined RadMaps metric ARM of sixty percent in the global analysis is much lower than either of those standalone metrics, which confirms that spatial mismatch is a critical factor here.

Mira: It really shows that when you look at these two constraints together, the resulting metric gives you a much clearer picture of what's actually happening on the ground compared to just looking at capacity or distance in isolation.

Lev: The paper does note some limitations, which I think is important for us to keep in mind. They mention assuming uniform cancer incidence which distributes cancer incidence uniformly across the population, and they treat all radiotherapy demand as equivalent when in reality the specific modality can vary a lot.

Kai: And another assumption they make is that their greedy nearest-first allocation algorithm assumes each facility serves its nearest patients first, which might actually overestimate access in settings where referral patterns diverge significantly from simple geographic proximity.

Mira: So, while RadMaps provides a valuable framework for visualizing and identifying these gaps at regional or global scales, we have to remember that the results are modeled proxies rather than direct empirical measures of what access looks like in reality.

Lev: The conclusion is that this paper demonstrates the value of modeling capacity and geographic constraints simultaneously to produce a combined metric that reveals deficits not captured by either constraint alone, and because its framework is open-access, it’s ready to be extended for larger-scale access modeling across different contexts.

Kai: It seems like RadMaps offers a useful tool for planners and policymakers who need a comprehensive way to evaluate infrastructure planning decisions concerning where radiotherapy services are needed most urgently.

Mira: Ultimately, the paper provides a flexible framework that helps move beyond looking at capacity or distance in isolation by showing how they interact to create a more complete picture of access challenges.

Conclusion: Kai: So we've looked at how RadMaps models radiotherapy access by balancing capacity and geography across different spatial scales—from Resolution-three down to Resolution-seven—and now we're getting to the conclusion of this work.

Mira: The authors call this framework RadMaps, and they’re using a hexagonal grid based on Uber’s H3 system to map population density against cancer incidence and facility locations.

Lev: What they do is calculate three metrics: capacity only, geography only, and the combined metric that factors both constraints in together.

Kai: The main thing here is that this combined metric shows you where you have a real problem because it captures that compounding effect we talked about earlier.

Mira: It seems like the authors are showing how this one unified metric can reveal access deficits even when capacity and geography constraints look different on their own.

Lev: They found that in their global analysis, the combined metric ARM is sixty percent, which is lower than either of those standalone metrics you saw before.

Kai: So what does that mean for planning? It means you can't just focus on one constraint when trying to decide where to build a new facility or how to distribute existing ones.

Mira: It suggests that spatial mismatch is a critical factor, and if you only look at capacity, you miss the geographic hurdles and vice versa.

Lev: If we were building real hardware for this kind of modeling, we’d have to worry about the computational overhead of running that kind of spatial intersection across all those resolutions.

Kai: That's a fair point, Lev. But what this paper really suggests is that this framework is modular and extensible, so it’s a good starting point for mapping out access challenges everywhere.

Mira: It’s an open-source tool that healthcare planners and researchers can take and adapt for different regions or even different types of medical access.

Lev: Yeah, the authors mention they have limitations, like assuming uniform cancer incidence across all areas, which is a big assumption you have to keep in mind.

Kai: Exactly. So while this framework gives us a powerful way to visualize these problems together, we still need to be careful about those underlying assumptions when we apply it in the real world.

Mira: That's the takeaway for now: RadMaps proves that modeling capacity and geography simultaneously gives you a better picture of access limitations than looking at them separately.

Lev: It’s a solid foundation, but next, we need to look at how this kind of spatial modeling translates into actual operational decisions for deploying new medical technology.

Laurence Wroea, Archie Brownb, Sophia Martinb, Alika Hob, Steinar Stapnesa

University of Oxford · University of Oslo

physics.med-ph

Submitted: 2026-05-22

Updated: 2026-10-28

Code: https://github.com/LaurenceWroe/Geospatial-modelling-radiotherapy-access

License: http://creativecommons.org/licenses/by/4.0/

Importance score: 88/100

The gist: RadMaps presents an open-source geospatial framework that simultaneously models capacity and geographic constraints on radiotherapy access at any spatial scale This tool is valuable because it…

Key concepts

H3 hexagonal grid
This is the specific coordinate system used by RadMaps for spatial analysis. It divides the Earth into uniform hexagons, allowing researchers to analyze radiotherapy access at different resolutions, from large regional areas down to very small local neighborhoods.
Demand and Access Modelling
This process calculates how many people need radiotherapy based on cancer incidence and utilization rates. It then apports this demand onto specific geographic areas (hexagons) to determine the local demand per area, which is essential for comparing it against available treatment capacity in that location.
Capacity-only metric (AC), Geography-only metric (AG), and Combined metric (ARM)
These are three different ways to measure access. AC measures access based only on facility capacity; AG measures access based only on geographic distance. ARM is the crucial combined metric that accounts for both constraints at the same time, showing the true level of effective access.
TravelTime API and Decay Functions
This component calculates travel times between locations using a specific API. It uses configurable functions like uniform or step decay to model how travel time changes based on distance, helping to accurately estimate how far patients can realistically reach a facility.

Terminology

Summary

RadMaps presents an open-source geospatial framework that simultaneously models capacity and geographic constraints on radiotherapy access at any spatial scale This tool is valuable because it addresses the compounding effect of capacity and geographic constraints to significantly reduce effective access

Modeling Constraints

RadMaps operates on Uber’s H3 hexagonal grid and integrates population density data with national cancer incidence estimates and radiotherapy facility inventories Radiotherapy demand is estimated using cancersite-specific radiotherapy utilisation rates Geographic access is modelled via configurable decay functions (uniform, step, or Weibull) using either distance, driving time, or public transport time A greedy nearest-first allocation algorithm assigns demand to facilities subject to both capacity and geographic constraints

Data and Demand Estimation

The framework uses three primary datasets: Population, Cancer Incidence, and Radiotherapy Facilities Population density data are taken from the Kontur Global Population Density dataset Cancer incidence estimates for 36 different cancer types across 185 countries are taken from GLOBOCAN 2022 Radiotherapy demand is calculated as D = X i λ ii (1) Demand is apportioned to individual hexagons to establish a local demand per hexagon Dh in proportion to their share of the total population

Access Metrics and Results

RadMaps calculates three metrics for capturing access: a capacity-only metric AC, a geography-only metric AG, and the RadMaps combined metric ARM The global analysis shows that capacity-only access is 70 %, geography-only access is 91 %, and the combined radiotherapy access is 60 % High-resolution analyses reveal distinct access profiles: capacity-limited (United Kingdom), geographically limited (Oman), and doubly constrained (India and Nigeria)

Framework Flexibility

The tool is designed to be flexible and extensible for infrastructure scenario modelling Users can add radiotherapy facilities in a user-defined or automatic way to evaluate the incremental impact of new facilities The implementation is in Python as an open-source tool presented as an interactive dashboard using pydeck with CARTO basemaps

Limitations and Interpretation

The paper notes several assumptions that must be considered, including uniform cancer incidence and no patient stratification for demand Furthermore, the geographic access model relies on configurable decay models without a universal empirical consensus on the relationship between travel distance or time and radiotherapy uptake The greedy nearest-first allocation assumes that each facility serves its nearest patients first, which may overestimate access in settings where referral patterns diverge significantly from geographic proximity The access metrics should therefore be interpreted as modelled proxies rather than empirical measures of realised access

Conclusion

RadMaps provides a flexible, open-access framework for visualising and identifying radiotherapy access gaps at regional to global scales The tool demonstrates the ability to distinguish qualitatively distinct access profiles and localise deficits at sub-national scale It is a foundation for larger-scale analyses of radiotherapy access and broader access modelling across diverse geographic and socioeconomic contexts

List of Abbreviations

API: Application Programming Interface DIRAC: Directory of Radiotherapy Centres EBRT: External Beam Radiotherapy GLOBOCAN: Global Cancer Observatory H3: Hexagonal Hierarchical Geospatial Indexing System IAEA: International Atomic Energy Agency MVM: Megavoltage Machine RT: Radiotherapy RTU: Radiotherapy Utilisation

Declarations

The authors declare no competing interests

Acknowledgements

The authors are thankful to TravelTime who provided extended APIusage and assistance with incorporating their data into the model, and to Walter Wuensch for feedback on the manuscript

Data Availability

This study uses publicly accessible data The RadMaps framework is available on GitHub https://github.com/LaurenceWroe/Geospatial-modelling-radiotherapy-access

References

Peter D Baade, Paramita Dasgupta, Joanne F Aitken, and Gavin Turrell. Distance to the closest radiotherapy facility and survival after a diagnosis of rectal cancer in queensland Michael B. p. 5

Where the paper says it

Geography-Only Access Metric The relationship between geographic access to radiotherapy and patient uptake and health outcomes is complex (Silverwood et al. While many studies demonstrate that increased travel distance or time is associated with reduced treatment uptake and poorer survival (Turner et al.

Barton, Susannah Jacob, Jesmin Shafiq, Karen Wong, Stephen R. p. 1
Where the paper says it

One of the principal treatment modalities for cancer is radiotherapy, which is required by approximately half of all patients for curative, adjuvant, or palliative purposes (Delaney et al. , 2005; Barton et al.

Thompson, Timothy P. Hanna, and Geoff P Delaney. p. 1
Where the paper says it

7 million deaths in 2022, projected to rise to approximately 35 million annual cases by 2050 (Bray et al. One of the principal treatment modalities for cancer is radiotherapy, which is required by approximately half of all patients for curative, adjuvant, or palliative purposes (Delaney et al.

Estimating the demand for radiotherapy from the evidence: A review of changes from 2003 to 2012 Freddie Bray, Mathieu Laversanne, Hyuna Sung, Jacques Ferlay, Rebecca L. Siegel, Isabelle Soerjomataram, and Ahmedin Jemal. Global cancer statistics 2022: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries Katrina F. p. 3
Where the paper says it

Cancer Incidence. Cancer incidence estimates for 36 different cancer types across 185 countries are taken from GLOBOCAN 2022 (Bray et al.

Brown, Harriet Rumgay, Catherine Dunlop, Michael Ryan, Robert Quartly, Amanda Cox, Anne Deas, Ruth Lyon, Lynn Beattie, Rowena Oliphant, Rebecca Ormiston-Rees, Gini Samuel, Claire White and Donald Max Parkin. The fraction of cancer attributable to modifiable risk factors in England Wales Scotland Northern Ireland and the United Kingdom in 2015 CartoDB. p. 0
Where the paper says it

RadMaps: A Geospatial Framework for Simultaneously Modelling Capacity and Geographic Constraints on Radiotherapy Access Laurence Wroea , Archie Brownb , Sophia Martinb , Alika Hob , Steinar Stapnesa,c aExceleray Sàrl, Versoix, Geneva, 1290, Switzerland bDepartment of Physics, University of Oxford, Keble Road, Oxford, OX1 3RH, United Kingdom cDepartment of Physics, University of Oslo, Sem Sælands vei 24, Oslo, 0371, Norway Abstract Background: Access to radiotherapy is constrained by two compounding factors: insufficient machine capacity to meet patient demand and geographic distance from treatment facilities. Existing analyses address these factors separately, constraining the insights available to planners and policymakers.

Carto basemap styles license Geoff Delaney, Susannah Jacob, Carolyn Featherstone, and Michael B Barton. p. 1
Where the paper says it

One of the principal treatment modalities for cancer is radiotherapy, which is required by approximately half of all patients for curative, adjuvant, or palliative purposes (Delaney et al. , 2005; Barton et al.

The role of radiotherapy in cancer treatment Peter Dunscombe, Cai Grau, Noémie Defourny, Julian Malicki, Josep M Borras, Mary Coffey et al. p. 1
Where the paper says it

The majority of radiotherapy is delivered via external beam radiotherapy (EBRT), in which a megavoltage machine (MVM) — predominantly a linear accelerator (linac) — delivers a targeted beam of ionising radiation to damage cancer cells (Healy et al. Operating these machines is resource-intensive: linacs are expensive, require stable local infrastructure, dedicated shielding, and ongoing maintenance, and their clinical operation requires a multidisciplinary team of oncologists, medical physicists, dosimetrists, nurses, and engineers (Dunscombe et al.

Guidelines for equipment and staffing of radiotherapy facilities in the european countries: Final results of the estro-hero survey Miranda M Fidler, Isabelle Soerjomataram, and Freddie Bray. p. 3
Where the paper says it

Cancer incidence estimates for 36 different cancer types across 185 countries are taken from GLOBOCAN 2022 (Bray et al. Radiotherapy Facilities.

A global view on cancer incidence and national levels of the human development index Sharad Goyal, Sheenu Chandwani, Bruce G Haffty, and Kitaw Demissie. p. 2
Where the paper says it

This paper presents RadMaps, an open-source geospatial tool that simultaneously models capacity and geographic constraints on radiotherapy access at any spatial scale, from sub-national to global. The tool operates on a hexagonal spatial grid and combines high-resolution population density data with national site-specific cancer incidence estimates, radiotherapy facility inventories and locations, and configurable geographic access decay functions.

Effect of travel distance and time to radiotherapy on likelihood of receiving mastectomy B J Healy, D van der Merwe, K E Christaki, and A Meghzifene. p. 0
Where the paper says it

Methods: RadMaps operates on Uber’s H3 hexagonal grid and integrates population density data with national cancer incidence estimates and radiotherapy facility inventories. Radiotherapy demand is estimated using cancersite-specific radiotherapy utilisation rates, and geographic access is modelled via configurable decay functions (uniform, step, or Weibull) using either distance, driving time, or public transport time, with travel times obtained via the TravelTime API.

Cobalt-60 machines and medical linear accelerators: Competing technologies for external beam radiotherapy Kontur, Inc. p. 1
Where the paper says it

The majority of radiotherapy is delivered via external beam radiotherapy (EBRT), in which a megavoltage machine (MVM) — predominantly a linear accelerator (linac) — delivers a targeted beam of ionising radiation to damage cancer cells (Healy et al. Operating these machines is resource-intensive: linacs are expensive, require stable local infrastructure, dedicated shielding, and ongoing maintenance, and their clinical operation requires a multidisciplinary team of oncologists, medical physicists, dosimetrists, nurses, and engineers (Dunscombe et al.

Kontur population dataset Fabio Y Moraes, Andre G Gouveia, Vanessa Freitas Bratti, Edward C Dee et al. p. 3
Where the paper says it

Population. Population density data are taken from the Kontur Global Population Density dataset (Kontur, Inc.

Global linear accelerator requirements and personalised country recommendations: a crosssectional population-based study Sierra M Silverwood, Kathleen Waeldner, Sasha K Demeulenaere et al. p. 1
Where the paper says it

The first is a capacity constraint. The majority of radiotherapy is delivered via external beam radiotherapy (EBRT), in which a megavoltage machine (MVM) — predominantly a linear accelerator (linac) — delivers a targeted beam of ionising radiation to damage cancer cells (Healy et al.

The relationship between travel distance for treatment and outcomes in patients undergoing radiation therapy: A systematic review TravelTime. p. 5
Where the paper says it

Geography-Only Access Metric The relationship between geographic access to radiotherapy and patient uptake and health outcomes is complex (Silverwood et al. While many studies demonstrate that increased travel distance or time is associated with reduced treatment uptake and poorer survival (Turner et al.

TravelTime API documentation Melanie Turner, Romi Carriere, Shona Fielding, George Ramsay, Leslie Samuel, Andrew Maclaren, and Peter Murchie. p. 0
Where the paper says it

Methods: RadMaps operates on Uber’s H3 hexagonal grid and integrates population density data with national cancer incidence estimates and radiotherapy facility inventories. Radiotherapy demand is estimated using cancersite-specific radiotherapy utilisation rates, and geographic access is modelled via configurable decay functions (uniform, step, or Weibull) using either distance, driving time, or public transport time, with travel times obtained via the TravelTime API.

The impact of travel time to cancer treatment centre on post-diagnosis care and mortality among cancer patients in scotland Melanie Turner, Samuel Kent, Sharon Hanley, and Peter Murchie. p. 5
Where the paper says it

Geography-Only Access Metric The relationship between geographic access to radiotherapy and patient uptake and health outcomes is complex (Silverwood et al. While many studies demonstrate that increased travel distance or time is associated with reduced treatment uptake and poorer survival (Turner et al.

Exploring associations between travel burden clinical features and outcomes from head and neck cancer in scotland uk Uber. p. 5
Where the paper says it

, 2011; Goyal et al. , 2014), other research suggests a more nuanced picture where greater travel distances can even correlate with superior clinical outcomes (Turner et al.

h3: Hexagonal hierarchical geospatial indexing system Dominik Wawrzuta, Justyna Klejdysz, Katarzyna Pędziwiatr, and Marzanna Chojnacka. p. 2
Where the paper says it

We describe the methodology, evaluate it through demonstration across a range of geographic and socioeconomic contexts, and discuss limitations and directions for future work. Spatial Framework RadMaps operates on H3, a hierarchical geospatial indexing system developed by Uber that partitions the globe into hexagonal cells at 16 discrete resolutions (Uber, 2025).

Global access to radiotherapy: A geospatial analysis of current disparities and optimal facility placement Christopher P Wild, Elisabete Weiderpass, and Bernard W Stewart editors. p. 2
Where the paper says it

This can place a strain on populations living far from a facility, who may therefore receive suboptimal treatment or none at all (Silverwood et al. A recent geospatial analysis found that 76 % of the global population lives within 2 h of travel time to a radiotherapy facility, with this figure dropping to 17 % in low-income countries (Wawrzuta et al.

World Cancer Report: Cancer Research for Cancer Prevention E H Zubizarreta, E Fidarova, B Healy, and E Rosenblatt. p. 1
Where the paper says it

The first is a capacity constraint. The majority of radiotherapy is delivered via external beam radiotherapy (EBRT), in which a megavoltage machine (MVM) — predominantly a linear accelerator (linac) — delivers a targeted beam of ionising radiation to damage cancer cells (Healy et al.

Need for radiotherapy in low and middle income countries – the silent crisis continues

Appendix A

In all radiotherapy deficit plots, the colourbar scale is normalised between 1 and 200 patients per hexagon to allow direct comparison between countries Australia (a) Deficit per hexagon, ∆h (b) Access ratio per hexagon, Ah/Dh India (a) Deficit per hexagon, ∆h (b) Access ratio per hexagon, Ah/Dh Nigeria (a) Deficit per hexagon, ∆h (b) Access ratio per hexagon, Ah/Dh Oman (a) Deficit per hexagon, ∆h (b) Access ratio per hexagon, Ah/Dh United Kingdom (a) Deficit per hexagon, ∆h (b) Access ratio per hexagon, Ah/Dh United States (a) Deficit per hexagon, ∆h (b) Access ratio per hexagon, Ah/Dh

Figure 1

Modelling pipeline used by RadMaps to calculate radiotherapy access maps and metrics

Table 1

Global radiotherapy access metrics at H3 Resolution-3 with a 200 km stepfunction threshold

Table 2

National baseline statistics population cancer incidence and number of radiotherapy facilities and linacs

Table 3

National radiotherapy access metrics by country and travel modality at H3 Resolution-5 with a 2 h step-function threshold

Figure 4

The capacity-only (AC), geography-only (AG), and RadMaps (ARM) radiotherapy access metrics as a percentage of demand for the six analysed countries

Appendix A.1

Australia has sufficient capacity to meet its radiotherapy demand in full Australia has sufficient capacity to meet its radiotherapy demand in full, and only 7 % of its population lives more than 2 h from one of its 103 radiotherapy facilities

Appendix A.2

India has a theoretical capacity sufficient to only meet 46% of its total demand India has a theoretical capacity sufficient to only meet 46% of its total demand, and only 59 % of the population lives within a 2 h drive of a radiotherapy centre

Appendix A.3

Nigeria possesses a theoretical capacity to meet only 10 % of its national demand Nigeria possesses a theoretical capacity to meet only 10 % of its national demand, and only 23 % of the population lives within a 2 h drive of a centre

Appendix A.4

While Oman has sufficient theoretical capacity to meet its national demand, its 7 linacs are all located within 2 radiotherapy centres in Muscat in the northeast Oman has sufficient theoretical capacity to meet its national demand, and only 47 % of the population lives within a 2 h drive of a center

Appendix A.5

Radiotherapy centres are well distributed across the United Kingdom, with 99 % of the population living within a 2 h drive of a facility There is, however, insufficient absolute capacity, with only enough machines to meet 68 % of the demand

Appendix A.6

The United States possesses a substantial overall capacity that exceeds demand by more than 70 % The United States possesses a substantial overall capacity that exceeds demand by more than 70 %, and 98 % of the population living within a 2 h drive of a facility

Figure 3

Global distribution of radiotherapy deficit and access ratio at H3 Resolution-3

Appendix A.1 Australia

(a) Deficit per hexagon, ∆h (b) Access ratio per hexagon, Ah/Dh

Appendix A.2 India

(a) Deficit per hexagon, ∆h (b) Access ratio per hexagon, Ah/Dh

Appendix A.3 Nigeria

(a) Deficit per hexagon, ∆h (b) Access ratio per hexagon, Ah/Dh

Appendix A.4 Oman

(a) Deficit per hexagon, ∆h (b) Access ratio per hexagon, Ah/Dh

Appendix A.5 United Kingdom

(a) Deficit per hexagon, ∆h (b) Access ratio per hexagon, Ah/Dh

Appendix A.6 United States

(a) Deficit per hexagon, ∆h (b) Access ratio per hexagon, Ah/Dh

**Appendix A.

Green — the paper says it, and the page is printed. Red — no passage carries it, so treat that sentence as unverified. The same check runs on your own text: check a summary against its source, $5.

Improvements for AI systems

  1. Improved AI system can perform simultaneous modeling of radiotherapy access by integrating population density, cancer incidence, and facility inventories within a hexagonal H3 grid framework to calculate capacity-only access (AC), geography-only access (AG), and combined RadMaps access (ARM).

  2. The improved system can localize radiotherapy deficits at sub-national scales by applying the greedy nearest-first allocation algorithm to assign demand to facilities subject to both capacity and geographic constraints, producing a localised access metric for every H3 hexagon.

  3. The AI system can assess country-specific access profiles, such as capacity-limited (United Kingdom), geographically limited (Oman), or doubly-constrained (India and Nigeria), by comparing the three metrics across different spatial contexts.

  4. It can evaluate the incremental impact of new infrastructure scenarios by allowing users to add radiotherapy facilities dynamically, rerunning the algorithm after each addition to assess changes in access and deficit metrics.

Abstract

Access to radiotherapy is constrained by two compounding factors: insufficient machine capacity to meet patient demand and geographic distance from treatment facilities. Existing analyses address these factors separately, in turn constraining the insights available to advocates, planners and policymakers. This paper presents RadMaps, an open-source geospatial framework that simultaneously models capacity and geographic constraints on radiotherapy access at any spatial scale. RadMaps operates on Uber's H3 hexagonal grid and integrates population density data with GLOBOCAN 2024 annual cancer incidence estimates and the IAEA DIRAC facility inventory. Radiotherapy demand is estimated using cancer site-specific radiotherapy utilisation rates, and geographic access is modelled via configurable decay functions (step, exponential, Gaussian, or power law) of distance or driving time. A capped three-step floating catchment area (3SFCA) method allocates demand to facilities subject to both capacity and geographic constraints, producing a localised access metric for every H3 hexagon. Globally, RadMaps estimates that installed capacity could meet 68.5% of radiotherapy demand, and 73.0% of demand is within geographic reach of a facility (2 h driving time with Gaussian decay, H3 Resolution-5), both comparable with published estimates. When both constraints apply, only 60.0% is met, leaving 3.7 million patients per year untreated. Countries are also grouped into one of four access profiles: strong access, capacity constrained, geography constrained, and doubly constrained. RadMaps provides a flexible, open-source framework for analysing, visualising and identifying radiotherapy access gaps at regional to global scales, with applications in advocacy, infrastructure planning, and policy prioritisation. Its modular framework is also extensible to other spatial access modelling applications.

Related papers